机构投资者调整了Abbott实验室的股权,按每股1.26美元的估计收入计算。 Institutional investors adjust stakes in Abbott Labs, which met earnings estimates at $1.26 per share.

Mawer投资管理有限公司和其他机构投资者一直在买卖Abbott实验室(ABT)的股份,Mawer公司将其股份减少了3.3%。 Mawer Investment Management Ltd. and other institutional investors have been buying and selling shares of Abbott Laboratories (ABT), with Mawer reducing its holdings by 3.3%. 尽管有这些变化,ABT报告每股收益为1.26美元,符合估计,收入为11.14亿美元. Despite these changes, ABT reported earnings of $1.26 per share, meeting estimates, and a strong revenue of $11.14 billion. ABT的市场上限为2 197.1亿美元,红利收益为1.87%,最近的股息为每股0.59美元。 ABT has a market cap of $219.71 billion and a dividend yield of 1.87%, with a recent dividend of $0.59 per share. 分析师给予“适度买入”评级，目标价为 144.47 美元。 Analysts have a "Moderate Buy" rating with a price target of $144.47.